Treatment Cost Analysis of COVID-19 in patients Treated at a University Hospital in Turkey

Basit Öğe Kaydı
dc.contributor.authorBozdemir, Enver
dc.contributor.authorBalbay, Öner Abidin
dc.contributor.authorTerzi, Melek
dc.contributor.authorKaplan, Zekeriya
dc.date.accessioned2023-07-26T11:54:25Z
dc.date.available2023-07-26T11:54:25Z
dc.date.issued2021
dc.departmentDÜ, İşletme Fakültesi, Sağlık Yönetimi Bölümüen_US
dc.departmentDÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göğüs Hastalıkları Ana Bilim Dalıen_US
dc.description.abstractObjective: To guide both the hospital management and the health policymakers who play a role in the management process of their disease by analysing the costs of the patients receiving inpatient treatment in Diizce University Health Application and Research Center (Hospital - DUHARH) due to coronavirus disease 2019 (COVID-19) from the perspective of the Social Security Institution (SSI). Methods: The study covers 582 patients who received inpatient treatment in intensive care and other clinics in March/2020-December/2020 due to COVID-19 disease in DUHARH. In the study, all sample unselected populations were included. Retrospectively obtained data were analysed using bottom-up, document analysis, and multivariate regression analysis. Results: It was determined that 60% of the 582 patients studied were male (350 people), 40% female (232 people) and that the average hospitalization period was 5.7 days, 23% (134 people) in the Pandemic Intensive Care Unit and 77% (448 people) in other pandemic services. The total amount invoiced to SSI by the hospital was 7.378.695,00 TRY ($ 1,052,595). It was determined that 79% of this was the intervention cost and the average daily hospitalization cost per patient was +/- 2,099.80 TRY ($ 299.54). Besides, since gender discrimination is male, elderly patients are hospitalized in intensive care. The hospitalization period is P<0.05. It was observed that medicine, material, intervention, and examination costs have increased. Conclusions: In the study conducted, it was observed that the increase in men, age and hospitalization period, and treatment in intensive care increased the costs, and among these, the intervention costs were the highest. To reduce the cost of illness, it is necessary to use lower-cost factors to eliminate the disease rate with restrictions and ultimately to vaccinate the whole population as soon as possible.en_US
dc.identifier.doi10.18521/ktd.905115
dc.identifier.endpage428en_US
dc.identifier.issn1309-3878
dc.identifier.startpage421en_US
dc.identifier.urihttps://doi.org/10.18521/ktd.905115
dc.identifier.urihttps://hdl.handle.net/20.500.12684/12829
dc.identifier.volume13en_US
dc.identifier.wosWOS:000901301900008en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorBozdemir, Enver
dc.institutionauthorBalbay, Öner Abidin
dc.institutionauthorTerzi, Melek
dc.institutionauthorKaplan, Zekeriya
dc.language.isoenen_US
dc.publisherDuzce Univ, Fac Medicineen_US
dc.relation.ispartofKonuralp Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.subjectCovid-19; Cost Of Illness; Cost Of Treatment; Cost Managementen_US
dc.subjectTop-Downen_US
dc.titleTreatment Cost Analysis of COVID-19 in patients Treated at a University Hospital in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
12829.pdf
Boyut:
594.62 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu